Irreversible, uselektive monoaminoksidasehemmere
Open Access
- 16 April 2009
- journal article
- abstracts
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 129 (8) , 746-8
Abstract
Irreversible, non-selective monoamine oxidase (MAO) inhibitors were among the first antidepressants. No drugs in this group are currently marketed in Norway, but many physicians will see patients using them, as they can be prescribed on a named patient basis after application to the Norwegian Medicines Agency. This article presents adverse effects, interactions and precautions related to the use of these drugs.Keywords
This publication has 2 references indexed in Scilit:
- The Monoamine Oxidase Inhibitor—Tyramine InteractionThe Journal of Clinical Pharmacology, 1989
- Diet and Monoamine Oxidase Inhibitors: A Re-ExaminationThe Canadian Journal of Psychiatry, 1984